Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
VanEck Oil Services ETF
OIH
No Data
Invivyd to Participate in Upcoming Investor Events
BTIG Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $10
Invivyd: Buy Rating Reiterated as Clinical and Regulatory Progress Supports Unchanged $10 Price Target
Invivyd Shareholders Reelect Board, Ratify PwC Auditor
Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), Century Therapeutics (IPSC)
Invivyd Price Target Maintained With a $10.00/Share by BTIG